Cargando…
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
PDE type 5 inhibitors (PDE5Is), such as sildenafil, tadalafil and vardenafil, are a class of drugs used to prolong the physiological effects of NO/cGMP signalling in tissues through the inhibition of cGMP degradation. Although these agents were originally developed for the treatment of hypertension...
Autores principales: | Tzoumas, Nikolaos, Farrah, Tariq E., Dhaun, Neeraj, Webb, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707100/ https://www.ncbi.nlm.nih.gov/pubmed/31721165 http://dx.doi.org/10.1111/bph.14920 |
Ejemplares similares
-
NO and hepatocellular cancer
por: Wang, Ronghua, et al.
Publicado: (2019) -
Infective endocarditis in the 21st century
por: Nappi, Francesco, et al.
Publicado: (2020) -
Reforming Cardiovascular Care in the United States towards High-Quality Care at Lower Cost with Examples from Model Programs in the State of Michigan
por: Alyeshmerni, Daniel, et al.
Publicado: (2014) -
The HEART Pathway and Hospital Cost Savings
por: Yau, Amy A., et al.
Publicado: (2017) -
My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
por: Carter, Barrie J.
Publicado: (2020)